NCT00892736 2018-06-29Veliparib in Treating Patients With Malignant Solid Tumors That Do Not Respond to Previous TherapyNational Cancer Institute (NCI)Phase 1 Completed98 enrolled
NCT00526617 2017-11-21A Phase I Study of ABT-888 in Combination With Temozolomide in Cancer PatientsAbbViePhase 1 Completed41 enrolled
NCT02009631 2017-11-20A Study to Evaluate the Effects of Veliparib on Heart Rhythms in Patients With Solid TumorsAbbViePhase 1 Completed45 enrolled
NCT02033551 2016-09-27A Study Evaluating Veliparib as a Single Agent or in Combination With Chemotherapy in Subjects With Solid TumorsAbbViePhase 1 Completed47 enrolled